Our estimation of positivity of breast cancers for our panel may have been conservative since we have been very stringent in calling expression positive, explaining why our rates of expression for GLUT1, CAIX, EGFR, MET, TfR, CAXII, and Mammaglobin are on the lower side compared to the literature [22,34-43]. The gene discussed is TFRC; the disease is breast cancer.